Analysis of the European Cardiac Biomarkers Diagnostics Market

Analysis of the European Cardiac Biomarkers Diagnostics Market

High Prevalence of Heart Disease Propels Market Growth

RELEASE DATE
23-Aug-2012
REGION
Europe
Research Code: M80A-01-00-00-00
SKU: HC01968-EU-MR_07170
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC01968-EU-MR_07170
$4,950.00
DownloadLink
ENQUIRE NOW

Description

The increase in demand for high quality cardiac testing has made diagnostic companies to diversify their products and shift towards genetic biomarkers and advanced point-of-care diagnostics. This research service analyses the cardiac biomarkers diagnostics market in Europe, particularly, for Acute Myocardial Infarction (AMI) and Congestive Heart Failure (CHF). It provides competitive landscape analysis, market share analysis, revenue forecasts, market engineering measurements, key trends and product profiles, along with strategic recommendations. The regional market analysis includes the United Kingdom, Germany, France, Italy, Spain, Benelux and Scandinavia. The period covered in the study is 2008-2018.

Table of Contents

Executive Summary of the European Cardiac Diagnostics Market

  • Title Slide Contact Details and Table of contents
  • Executive Summary
  • Executive Summary—Market Engineering Measurements
  • Executive Summary—CEO’s Perspective

Market Overview

  • Market Overview—Definitions
  • Market Overview—Key Questions This Study Will Answer
  • Market Overview—Research Aim and Scope
  • Market Overview—Segmentation

External Challenges: Drivers and Restraints—Total Cardiac Biomarkers Diagnostics Market

  • Drivers and Restraints
  • Drivers Explained
  • Restraints Explained
  • Impact Mapping of Drivers and Restraints

Forecast and Trends—Total Cardiac Biomarkers Diagnostics Market

  • Market Engineering Measurements
  • Forecast Assumptions
  • Total Cardiac Biomarkers Diagnostics Market Revenue Forecast
  • Revenue Forecast Discussion

Market Share and Competitive Analysis—Total Cardiac Biomarkers Diagnostics Market

  • Competitive Analysis—Market Share
  • Market Share Analysis
  • Competitive Environment
  • Competitive Landscape Analysis
  • Competitive Analysis—Selected Key Market Participants

AMI Biomarkers Diagnostics Segment Breakdown

  • Market Overview
  • AMI Biomarkers Diagnostics Segment—Market Engineering Measurements
  • AMI Biomarkers Diagnostics Segment Revenue Forecast
  • Revenue Forecast Discussion
  • AMI Biomarkers Diagnostics Segment—Market Metrics Analysis
  • Competitive Analysis—Market Share
  • Market Share Analysis
  • Competitive Environment
  • Competitive Factors and Assessment
  • Product Profiles

CHF Biomarkers Diagnostics Segment Breakdown

  • Market Overview
  • CHF Marker Diagnostics Segment—Market Engineering Measurements
  • CHF Biomarkers Diagnostics Segment Revenue Forecast
  • Revenue Forecast Discussion
  • CHF Biomarkers Diagnostics Segment—Market Metrics Analysis
  • Competitive Analysis—Market Share
  • Market Share Analysis
  • Competitive Environment
  • Competitive Factors and Assessment
  • Product Profiles

Regional Analysis

  • Regional Overview
  • The United Kingdom Breakdown
  • The United Kingdom Market—Introduction
  • The United Kingdom Market—Market Engineering Measurements
  • The United Kingdom Market—Revenue Forecast
  • The United Kingdom Market—Revenue Forecast Discussion
  • Germany Breakdown
  • Germany Market—Introduction
  • Germany Market—Market Engineering Measurements
  • Germany Market—Revenue Forecast
  • Germany Market—Revenue Forecast Discussion
  • France Breakdown
  • France Market—Introduction
  • France Market—Market Engineering Measurements
  • France Market—Revenue Forecast
  • France Market—Revenue Forecast Discussion
  • Italy Breakdown
  • Italy Market—Introduction
  • Italy Market—Market Engineering Measurements
  • Italy Market—Revenue Forecast
  • Italy Market—Revenue Forecast Discussion
  • Spain Breakdown
  • Spain Market—Introduction
  • Spain Market—Market Engineering Measurements
  • Spain Market—Revenue Forecast
  • Spain Market—Revenue Forecast Discussion
  • The Benelux Breakdown
  • The Benelux Market—Introduction
  • The Benelux Market—Market Engineering Measurements
  • The Benelux Market—Revenue Forecast
  • The Benelux Market—Revenue Forecast Discussion
  • Scandinavia Breakdown
  • Scandinavia Market—Introduction
  • Scandinavia Market—Market Engineering Measurements
  • Scandinavia Market—Revenue Forecast
  • Scandinavia Market—Revenue Forecast Discussion

Conclusions and Strategic Recommendations

  • Conclusions
  • Strategic Recommendations

The Last Word (Conclusions and Implications)

  • The Last Word—Three Big Predictions
  • Legal Disclaimer

Appendix

  • Market Engineering Methodology
  • Other Related Studies
  • Prevalence of Cardiovascular Diseases
  • Coronary Heart Disease
  • New Cases of Heart Attack
The increase in demand for high quality cardiac testing has made diagnostic companies to diversify their products and shift towards genetic biomarkers and advanced point-of-care diagnostics. This research service analyses the cardiac biomarkers diagnostics market in Europe, particularly, for Acute Myocardial Infarction (AMI) and Congestive Heart Failure (CHF). It provides competitive landscape analysis, market share analysis, revenue forecasts, market engineering measurements, key trends and product profiles, along with strategic recommendations. The regional market analysis includes the United Kingdom, Germany, France, Italy, Spain, Benelux and Scandinavia. The period covered in the study is 2008-2018.
More Information
No Index Yes
Podcast No
Author Srinivas Sashidhar
Industries Healthcare
WIP Number M80A-01-00-00-00
Is Prebook No